Amphastar Pharmaceuticals, Inc. (AMPH) Financial Statements (2026 and earlier)

Company Profile

Business Address 11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments221,645256,806175,762136,673105,61985,360
Cash and cash equivalent151,609144,296156,098126,35392,64273,685
Short-term investments70,036112,51019,66410,32012,97711,675
Restricted cash and investments2,4352,4352,4352,4354,0654,190
Receivables136,289114,94388,80478,80466,00545,376
Inventory, net of allowances, customer advances and progress billings153,741105,833103,58492,80796,831110,501
Inventory153,741105,833103,58492,80796,831110,501
Other undisclosed current assets19,9619,5837,7347,4007,1629,814
Total current assets:534,071489,600378,319318,119279,682255,241
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization383564753353612887
Operating lease, right-of-use asset46,89932,33325,55426,89420,04218,805
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization297,345282,746238,266244,244260,055233,856
Long-term investments and receivables 10,99614,6852,4143,985  
Long-term investments 10,99614,6852,4143,985  
Intangible asset, including goodwill, after accumulated amortization, including:590,660613,29537,29838,87040,61541,153
Goodwill3,0493,2163,1263,3133,9403,634
Intangible asset, excluding goodwill, after accumulated amortization587,586610,05434,14735,53236,6508,294
Other undisclosed intangible asset, including goodwill, after accumulated amortization252525252529,225
Deferred income tax assets71,12453,25238,52722,39924,98025,873
Other noncurrent assets25,99225,91020,85616,6655,25011,156
Other undisclosed noncurrent assets  527    
Total noncurrent assets:1,043,3991,023,312363,668353,410351,554331,730
TOTAL ASSETS:1,577,4701,512,912741,987671,529631,236586,971
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities157,05793,36684,24289,54595,50477,051
Accounts payable30,51425,43820,50122,21424,35725,061
Accrued liabilities126,54367,92863,74167,33171,14751,990
Debt2344363,0462,20212,2637,741
Other undisclosed current liabilities16,468131,6057,57412,0634,4345,217
Total current liabilities:173,759225,40794,862103,810112,20190,009
Noncurrent Liabilities
Long-term debt and lease obligation, including:601,630589,57972,83974,77634,18639,394
Long-term debt, excluding current maturities613,532603,17476,64278,18545,92346,324
Finance lease, liability432616790398  
Other undisclosed long-term debt and lease obligation(12,334)(14,211)(4,593)(28,510)(29,201)(23,245)
Liabilities, other than long-term debt69,78358,50545,62822,71818,66213,725
Accounts payable and accrued liabilities6,9576,0667,2256,5314,7093,425
Deferred income tax liabilities   144534741867
Other liabilities20,94522,71814,56515,65313,2129,433
Operating lease, liability41,88129,72123,69424,70317,46416,315
Other undisclosed noncurrent liabilities    24,70317,46416,315
Total noncurrent liabilities:671,413648,084118,467122,19770,31269,434
Total liabilities:845,172873,491213,329226,007182,513159,443
Equity
Equity, attributable to parent732,298639,421528,658445,522402,306381,366
Common stock666655
Treasury stock, value(332,714)(247,431)(189,524)(150,479)(121,812)(97,627)
Additional paid in capital505,400486,056455,077422,423410,061367,305
Accumulated other comprehensive loss(9,181)(8,478)(8,624)(6,765)(3,721)(4,687)
Retained earnings568,787409,268271,723180,337117,773116,370
Equity, attributable to noncontrolling interest     46,41746,162
Total equity:732,298639,421528,658445,522448,723427,528
TOTAL LIABILITIES AND EQUITY:1,577,4701,512,912741,987671,529631,236586,971

Income Statement (P&L) ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues731,967644,395498,987437,768349,846322,357
Cost of revenue(358,112)(293,274)(250,127)(238,029)(206,506)(190,434)
Gross profit:373,855351,121248,860199,739143,340131,923
Operating expenses(168,436)(154,134)(141,363)(129,852)(132,386)(131,962)
Operating income (loss):205,419196,987107,49769,88710,954(39)
Nonoperating income (expense)(15,655)(25,628)8,54314,252(6,317)60,267
Investment income, nonoperating10,6125,4591,321601642997
Other nonoperating income (expense)4,076(3,929)9,06814,536(6,585)59,389
Interest and debt expense(30,343)(27,158)(1,846)(885)(374)(119)
Income from continuing operations before equity method investments, income taxes:159,421144,201114,19483,2544,26360,109
Other undisclosed income from continuing operations before income taxes30,34327,1581,846885374119
Income from continuing operations before income taxes:189,764171,359116,04084,1394,63760,228
Income tax expense(29,672)(31,833)(23,477)(20,630)(3,540)(13,723)
Income from continuing operations:160,092139,52692,56363,5091,09746,505
Income before gain (loss) on sale of properties:63,5091,09746,505
Other undisclosed net loss (573)(1,981)(1,177)(208)  
Net income:159,519137,54591,38663,3011,09746,505
Net income (loss) attributable to noncontrolling interest    (1,185)3062,434
Net income available to common stockholders, diluted:159,519137,54591,38662,1161,40348,939

Comprehensive Income ($ in thousands)

12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income:159,519137,54591,38663,3011,09746,505
Comprehensive income:159,519137,54591,38663,3011,09746,505
Comprehensive income (loss), net of tax, attributable to noncontrolling interest    (1,185)3062,434
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(703)146(1,859)(3,044)966(674)
Comprehensive income, net of tax, attributable to parent:158,816137,69189,52759,0722,36948,265

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: